Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the landscape of symptom-specific inflammatory cytokines in post-COVID syndrome patients.
Tilikete C, Zamali I, Meddeb Z, Kharroubi G, Marzouki S, Dhaouadi T, Ben Hmid A, Samoud S, Galai Y, Charfeddine S, Abid L, Abdessalem S, Bettaieb J, Hamzaoui S, Bouslama K, Ben Ahmed M. Tilikete C, et al. Among authors: zamali i. BMC Infect Dis. 2024 Nov 22;24(1):1337. doi: 10.1186/s12879-024-10222-5. BMC Infect Dis. 2024. PMID: 39578766 Free PMC article.
Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients.
Ben Khlil AA, Zamali I, Belloumi D, Gdoura M, Kharroubi G, Marzouki S, Dachraoui R, Ben Yaiche I, Bchiri S, Hamdi W, Gharbi M, Ben Hmid A, Samoud S, Galai Y, Torjmane L, Ladeb S, Bettaieb J, Triki H, Ben Abdeljelil N, Ben Othman T, Ben Ahmed M. Ben Khlil AA, et al. Among authors: zamali i. Vaccines (Basel). 2024 Feb 8;12(2):174. doi: 10.3390/vaccines12020174. Vaccines (Basel). 2024. PMID: 38400157 Free PMC article.
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.
Samoud S, Bettaieb J, Gdoura M, Kharroubi G, Ben Ghachem F, Zamali I, Ben Hmid A, Salem S, Gereisha AA, Dellagi M, Hogga N, Gharbi A, Baccouche A, Gharbi M, Khemissi C, Akili G, Slama W, Chaieb N, Galai Y, Louzir H, Triki H, Ben Ahmed M. Samoud S, et al. Among authors: zamali i. Vaccines (Basel). 2023 Aug 5;11(8):1329. doi: 10.3390/vaccines11081329. Vaccines (Basel). 2023. PMID: 37631897 Free PMC article.
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Beldi-Ferchiou A, Jais JP, Ghesquieres H, Casasnovas RO, Tilly H, Fruchart C, Morschhauser F, Haioun C, Lazarovici J, Perrot A, Nicolas-Virelizier E, Salles G, Godard N, Zamali I, De Colella JS, Claudel A, Corront B, Oberic L, Briere J, Gaulard P, Thieblemont C, Delfau-Larue MH. Beldi-Ferchiou A, et al. Among authors: zamali i. Br J Haematol. 2023 Apr;201(2):256-266. doi: 10.1111/bjh.18642. Epub 2023 Feb 6. Br J Haematol. 2023. PMID: 36740991 Clinical Trial.
Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa).
Ben Ahmed M, Bellali H, Gdoura M, Zamali I, Kallala O, Ben Hmid A, Hamdi W, Ayari H, Fares H, Mechri K, Marzouki S, Triki H, Ben Alaya N, Chahed MK, Klouz A, Sebai Ben Amor S, Ben Rayana C, Razgallah Khrouf M, Hamouda C, Elkadri N, Daghfous R, Trabelsi A. Ben Ahmed M, et al. Among authors: zamali i. Vaccines (Basel). 2022 Jul 27;10(8):1189. doi: 10.3390/vaccines10081189. Vaccines (Basel). 2022. PMID: 35893838 Free PMC article.
16 results